前段光学连贯断层扫描生物参数在非对称初级角关闭疾病的发病过程中的决定性作用

Rongrong Li1,2,3, Yi Cai4,5,6, Yun Zhao4,5,6

  • 1Hebei Eye Hospital, No. 399 Quanbei Dong Dajie, Xingtai City, Hebei Province, People's Republic of China. lvshuisuohan@163.com.

BMC ophthalmology
|October 24, 2025
PubMed
概括

主角闭眼光眼 (PACG) 的眼睛显示了一个更拥挤的前段. 关键因素包括更高的透镜圆顶 (LV) 和更窄的虹膜膜角 (TIA750),更小的角度开口距离 (AOD750),以及轨道虹膜空间面积 (TISA750).

相关概念视频

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
958